French Study to Highlight the Unmet Treatment Needs of 3L+ CP-CML and With T315I-mutated CML Patients
Clinical trial NCT05619978 · COMPLETED
Trial details
- NCT number
- NCT05619978
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-03
- Primary completion
- 2021-10-29
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.